The focus of current research study was to evaluate the influence of the
seed extract of Citrullus lanatus on urea, creatinine, potassium, sodium,
chloride and bicarbonate in streptozotocin induced diabetic rats.
Eighteen male wistar albino rats were divided into six groups of three
rats each, diabetes were induced in all the rats except group 1 by intraperitoneal injection of 45 mg/kg b.wt. of streptozotocin. Group 1 rats
served as control and received standard feed and water daily; Group 2
rats received oral Glibenclamide (0.5 mg/kg bw); Group 3,4, and 5
received 200 mg/kg bw, 400 mg/kg bw and 600 mg/kg b.wt. of the
ethanolic extract of Citrullus lanatus seed respectively; and group 6
served as diabetic group. Blood samples were collected and analysed for
urea, creatinine, potassium, sodium, chloride and bicarbonate using
urease-Berthelot colorimetric method, Jaffe’s colorimetric method and
Ion selective electrode (ISE) method respectively. There was a significant
decrease in (p<0.05) glucose concentration (mmol/L) of 3.90 in control
compared to 8.07, 8.73, 14.67, 11.43 and 9.80 in albino rats treated with
glibenclamide, STZ+CLS 200 mg, STZ+CLS 400 mg, STZ+CLS 600 mg and
diabetic control respectively. In potassium concentration (meq/l) 6.51
in control compared with 4.97, 7.59, 7.28, 8.45 and 6.87 in albino rats
treated with glibenclamide, STZ+CLS200 mg, STZ+CLS 400 mg, STZ+CLS
600 mg and diabetic control respectively. While in sodium concentration
(meq/l) of 1.42 in control compared to 1.33, 1.30, 1.36, 1.42 and 1.36
in albino rats treated with glibenclamide, STZ+CLS 200 mg, STZ+CLS 400
mg, STZ+CLS 600 mg and diabetic control respectively. However, in
chloride concentration (meq/l) of 1.06 in control compared to 99.10,
97.87, 1.04, 88.00, 1.04, 88.00 and 1.04 in albino rats treated with
glibenclamide, STZ+CLS 200 mg, STZ+CLS 400 mg, STZ+CLS 600 mg and
diabetic control respectively and also in bicarbonate concentration
(meq/l) of 10.07 when compared with 17.30, 16.47, 15.40, 6.40 and
17.30 in albino rats treated with glibenclamide, STZ+CLS 200 mg,
STZ+CLS 400 mg, STZ+CLS 600 mg and diabetic control respectively. In
conclusion, this medicinal plant could be considered as a potential and
alternative approach for the treatment of diabetes.
Keywords: Keywords: Citrullus lanatus, Diabetes Mellitus, Renal